Pet Product Company Financial Services: Scaling Pet Care Businesses

April 6, 2026

By: Paul Lembo

Partner, Assurance

Key Takeaways

Pet product companies operate across multiple cost structures simultaneously — manufactured goods, regulated ingredients, and channel-specific trade terms — and each one requires distinct accounting treatment to produce a reliable gross margin figure.
Revenue recognition under ASC 606 is not uniform across channels. DTC, wholesale, and marketplace sales each carry different return, allowance, and performance obligation characteristics that must be accounted for separately.
Inventory management in pet food and treat manufacturing is governed by FSMA compliance requirements, which create audit-trail obligations with direct accounting implications — particularly around lot traceability and recall reserve estimates.
Pet product companies that use co-manufacturers must carefully audit their COGS build-up. Contract manufacturing invoices routinely bundle costs that belong in COGS with costs that belong in operating expenses, and accepting that invoice at face value produces a distorted gross margin from day one.
Scaling into new retail channels is a cash flow event, not just a revenue event. The working capital requirements of a national retail launch — slotting fees, extended payment terms, promotional allowances, and initial inventory builds — must be planned and reflected in financial projections before the purchase order arrives.
Bottom line: The pet industry rewards brands that grow fast. It tends to penalize businesses whose financial operations weren’t built to scale alongside the product.

Pet product companies have a reputation for being founder-driven, passion-fueled businesses — and that reputation is largely accurate. What gets discussed less often is that the pet industry is also, structurally, one of the more demanding product business models from an accounting standpoint. Regulated ingredients, multi-channel distribution, co-manufacturing dependencies, and a consumer base that treats product recalls as brand-ending events combine to create a financial profile that requires more rigor than most founders anticipate when they are focused on growth.

The good news is that the accounting framework for a well-run pet product business is not complicated. It is specific. Understanding what goes where, and why, is what separates a business with financials that support scale from one that is perpetually explaining discrepancies to its lender, investor, or acquirer.

COGS: The Foundation That Pet Brands Frequently Get Wrong

Cost of goods sold for a pet product company — food, treats, supplements, accessories, or any combination — should capture every cost directly incurred to bring a unit of finished product into existence and to the point of first sale. Getting this right is the foundation of every other financial metric the business tracks.

For pet food and treat manufacturers using a contract manufacturer, COGS properly includes raw ingredient costs (proteins, fats, carbohydrates, vitamins, minerals), packaging materials (primary and secondary), contract manufacturing fees, inbound freight on materials, and any quality testing performed on finished goods prior to release. Certificate of analysis testing, microbiological testing, and nutritional panel verification — required under FDA’s Food Safety Modernization Act (FSMA) for pet food manufacturers — belong in COGS when they are directly attributable to a specific production run. When they relate to ongoing quality system maintenance rather than a specific lot, they belong in operating expenses.

For pet accessory and hardgood companies, COGS includes purchased product cost (or manufactured cost), inbound freight, and any assembly, kitting, or inspection costs incurred before the product is ready for sale.

What consistently ends up in the wrong place: new product formulation and development costs (operating expense, not COGS), packaging design fees (operating expense), product photography (operating expense), and trade show samples (operating expense). Each of these shows up on invoices during the same period as legitimate COGS, and without a disciplined classification policy, they migrate into cost of goods sold — depressing reported gross margin in periods of active development activity, and creating a misleading baseline for ongoing margin analysis.

Inventory: Lot Traceability, Expiration, and the Reserve Methodology

Pet food and treat companies subject to FDA’s FSMA requirements must maintain lot-level traceability for all ingredients and finished goods. This is a regulatory requirement, but it is also an accounting requirement: the lot traceability system is the foundation for estimating and recording inventory impairment when a lot becomes suspect, approaches its expiration date, or is involved in a voluntary recall.

Under U.S. GAAP, inventory must be carried at the lower of cost or net realizable value. Pet food and treat products carry explicit expiration dates. Product approaching expiration that cannot be sold through normal channels at full price — or at all — must be written down to its estimated net realizable value in the period the impairment becomes probable. This is not a judgment call; it is a requirement, and the analysis depends entirely on having accurate lot-level data by SKU.

The practical implication: pet food companies should maintain a monthly expiration report by lot and SKU that identifies at-risk inventory, estimates the expected disposition, and calculates the required write-down to net realizable value. For companies selling through retail channels with minimum remaining shelf life requirements — typically 75% of total shelf life for major grocery and pet specialty retailers — the effective write-down trigger is often well before the printed expiration date.

Recall reserve estimation is a related obligation. Companies with significant distribution in regulated product categories should maintain a recall reserve — an accrued liability representing the estimated cost of a product withdrawal or recall, including product retrieval, destruction, customer notification, and replacement. The estimate is inherently imprecise, but the absence of any reserve on a pet food company’s balance sheet is a gap that auditors and acquirers will identify.

Slotting Fees and the Cash Flow Reality of Retail Expansion

One of the most reliably underestimated financial events in a pet product company’s growth trajectory is the decision to enter a major retail channel. The revenue is visible. The cash flow requirements are not — until the purchase order arrives and the reality sets in.

Slotting fees — payments made to retailers for placement in their assortment — are a standard feature of the pet specialty and grocery retail channels. Under U.S. GAAP, slotting fees paid to secure shelf placement are generally recorded as a reduction of revenue rather than a marketing expense, unless the company receives a distinct benefit in return. They are recognized over the period of the arrangement — typically the expected period of benefit — rather than expensed immediately, unless the arrangement is short-term or the benefit period is indeterminate. Either way, the cash goes out before a unit is sold.

Beyond slotting fees, the working capital requirements of a retail launch include: extended payment terms (net 30 to net 60 is standard; net 90 is not uncommon for large national accounts), the initial inventory build required to stock distribution centers and store shelves before any revenue is recognized, and the promotional funding commitments that typically accompany a retail authorization — including introductory price reductions, feature advertising, and display allowances.

Companies that model retail channel expansion as a revenue line item without accounting for the corresponding working capital consumption frequently find themselves cash-constrained at precisely the moment when the business appears most successful from the outside. Planning these cash flow requirements in advance — and reflecting them in financial projections, loan covenants, and equity requirements — is what keeps the growth from becoming a liquidity problem.

Wiss Serves Pet Product Companies

The pet industry is one of the more durable consumer product categories, and the brands that generate the most enterprise value are generally those that combine strong product fundamentals with financial operations built to scale. The accounting infrastructure — the COGS methodology, the inventory management process, the revenue recognition policies, the channel-level margin analysis — needs to be put in place before the growth arrives, not constructed in response to an audit finding or a lender’s diligence request.

The businesses that get this right early find that the financials become an asset. They tell a credible story to investors, support smarter decisions internally, and hold up under the scrutiny that comes with any serious transaction or financing event.

The Wiss CPG advisory team works with consumer product companies — including pet brands at every stage of growth — on financial operations, tax planning, and the accounting structure that supports sustainable scale. If your financials need to grow as fast as your business, let’s talk.